Cargando...

Differential gene expression analysis of palbociclib-resistant TNBC via RNA-seq

PURPOSE: The management of triple-negative breast cancer (TNBC) remains a significant clinical challenge due to the lack of effective targeted therapies. Inhibitors of the cyclin-dependent kinases 4 and 6 (CDK4/6) are emerging as promising therapeutic agents against TNBC; however, cells can rapidly...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res Treat
Main Authors: Lanceta, Lilibeth, Lypova, Nadiia, O’Neill, Conor, Li, Xiaohong, Rouchka, Eric, Chesney, Jason, Imbert-Fernandez, Yoannis
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8019424/
https://ncbi.nlm.nih.gov/pubmed/33599863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-021-06127-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!